Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000385239 | SCV000449434 | uncertain significance | Asphyxiating thoracic dystrophy 5 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Illumina Laboratory Services, |
RCV000288576 | SCV000449435 | uncertain significance | Cranioectodermal dysplasia 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Ce |
RCV000488404 | SCV000575408 | uncertain significance | not provided | 2016-10-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000488404 | SCV000884899 | uncertain significance | not provided | 2023-10-09 | criteria provided, single submitter | clinical testing | The WDR19 c.3667C>T; p.Arg1223Cys variant (rs201597047), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 348754). This variant is found in the general population with an overall allele frequency of 0.16% (447/280632 alleles, including 3 homozygotes) in the Genome Aggregation Database. The arginine at position 1223 is moderately conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.750). Due to limited information, the clinical significance of this variant is uncertain at this time. |
Labcorp Genetics |
RCV001083150 | SCV001096889 | likely benign | Asphyxiating thoracic dystrophy 5; Senior-Loken syndrome 8 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530412 | SCV004711246 | benign | WDR19-related disorder | 2019-08-07 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |